Sanjay Chandru Keswani

CIK: 0001818524

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (12.5%)

Derivative conversions

Awards (A)5 (62.5%)

Compensation grants

Other (G, F, J, C, D, …)2 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NBIX

NEUROCRINE BIOSCIENCES INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

NBIX
NEUROCRINE BIOSCIENCES INC
Sep 11, 2026
Award(A)
Direct
3.9K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Sep 11, 2026
Tax Payment(F)
Direct
2.1K shares at avg. $156.22$330K
NBIX
NEUROCRINE BIOSCIENCES INC
Jun 2, 2026
Exercise(M)
Direct
3.2K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Jun 2, 2026
Tax Payment(F)
Direct
1.7K shares at avg. $154.84$268K
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Award(A)
Restricted Stock Unit
Direct
6.3K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Award(A)
Stock Option
Direct
35.8K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Jun 2, 2025
Award(A)
Restricted Stock Unit
Direct
12.8K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Jun 2, 2025
Award(A)
Stock Option
Direct
70.1K shares-

		Type	Shares	Price		Ownership
Sep 11, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Award(A)	3,914	-	$0	Direct
Sep 11, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	2,112	$156.22	$329,937	Direct
Jun 2, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	3,212	-	$0	Direct
Jun 2, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	1,733	$154.84	$268,338	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Award(A) Restricted Stock Unit	6,285	-	-	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Award(A) Stock Option	35,827	-	-	Direct
Jun 2, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Award(A) Restricted Stock Unit	12,846	-	-	Direct
Jun 2, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Award(A) Stock Option	70,101	-	-	Direct

1-8 of 8 transactions

About Keswani Sanjay Chandru

Keswani Sanjay Chandru (SEC CIK 0001818524) files insider reports with the SEC as Chief Medical Officer of NEUROCRINE BIOSCIENCES INC (NBIX).

Signal8 holds 5 ownership filings by Keswani Sanjay Chandru (1 Form 3, 4 Form 4), filed between Jun 4, 2025 and Sep 15, 2026. Those filings report 8 transactions, from Jun 2, 2025 to Sep 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Keswani Sanjay Chandru's filings is in SAN DIEGO, CA.

Recent filings by Keswani Sanjay Chandru

Sep 11, 2026: Grant or award of NBIX shares (Form 4, code A).
Sep 11, 2026: Tax withholding of NBIX shares (Form 4, code F).
Jun 2, 2026: Option exercise of NBIX shares (Form 4, code M).
Jun 2, 2026: Tax withholding of NBIX shares (Form 4, code F).
Feb 13, 2026: Grants or awards of NBIX derivative securities (2 lines, Form 4, code A).

Other insiders filing for NEUROCRINE BIOSCIENCES INC (NBIX)

MORROW GEORGE J, Director
Gano Kyle, Chief Executive Officer
ROBERTS EIRY, Chief Medical Officer
Onyia Jude, Chief Scientific Officer
Lippoldt Darin, Chief Legal Officer
GORMAN KEVIN CHARLES, Director

How to read Form 4 transaction codes